Skip to main content
Top
Published in: Journal of Neurology 7/2016

Open Access 01-07-2016 | Original Communication

Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study

Authors: Lisanne J. Balk, Andrés Cruz-Herranz, Philipp Albrecht, Sam Arnow, Jeffrey M. Gelfand, Prejaas Tewarie, Joep Killestein, Bernard M. J. Uitdehaag, Axel Petzold, Ari J. Green

Published in: Journal of Neurology | Issue 7/2016

Login to get access

Abstract

The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell–inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1–45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (−1.1 µm, 95 % CI 1.4–0.7, p < 0.001) and mGCIPL (−1.1 µm, 95 % CI −1.4 to −0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (−0.03 µm, 95 % CI −0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury.
Literature
1.
go back to reference Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247–269CrossRefPubMed Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247–269CrossRefPubMed
2.
go back to reference Petzold A (2014) Neurodegeneration and multiple sclerosis. In: Galimberti D, Scaroini E (eds) Neurodegenerative diseases. Springer, London, pp 227–245CrossRef Petzold A (2014) Neurodegeneration and multiple sclerosis. In: Galimberti D, Scaroini E (eds) Neurodegenerative diseases. Springer, London, pp 227–245CrossRef
3.
go back to reference Dalton CM, Chard DT, Davies GR, Miszkiel KA, Altmann DR, Fernando K et al (2004) Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 127:1101–1107CrossRefPubMed Dalton CM, Chard DT, Davies GR, Miszkiel KA, Altmann DR, Fernando K et al (2004) Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 127:1101–1107CrossRefPubMed
4.
go back to reference De SN, Matthews PM, Filippi M, Agosta F, De LM, Bartolozzi ML et al (2003) Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 8 60(7):1157–1162CrossRef De SN, Matthews PM, Filippi M, Agosta F, De LM, Bartolozzi ML et al (2003) Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 8 60(7):1157–1162CrossRef
5.
go back to reference Calabrese M, Gallo P (2009) Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler 15(8):933–941CrossRefPubMed Calabrese M, Gallo P (2009) Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler 15(8):933–941CrossRefPubMed
6.
go back to reference Fisher E, Lee JC, Nakamura K, Rudick RA (2008) Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 64(3):255–265CrossRefPubMed Fisher E, Lee JC, Nakamura K, Rudick RA (2008) Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 64(3):255–265CrossRefPubMed
7.
go back to reference Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA et al (2008) Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 64(3):247–254CrossRefPubMed Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA et al (2008) Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 64(3):247–254CrossRefPubMed
8.
go back to reference Costello F (2013) The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis. ISRN Neurol 2013:134858PubMedPubMedCentral Costello F (2013) The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis. ISRN Neurol 2013:134858PubMedPubMedCentral
9.
go back to reference Martinez-Lapiscina E, Sanchez-Dalmau B, Fraga-Pumar E, Ortiz-Perez S, Tercero-Uribe A, Torres-Torres R et al (2014) The visual pathway as a model to understand brain damage in multiple sclerosis. Mult Scler 20(13):1678–1685CrossRefPubMed Martinez-Lapiscina E, Sanchez-Dalmau B, Fraga-Pumar E, Ortiz-Perez S, Tercero-Uribe A, Torres-Torres R et al (2014) The visual pathway as a model to understand brain damage in multiple sclerosis. Mult Scler 20(13):1678–1685CrossRefPubMed
10.
go back to reference Balk LJ, Twisk JW, Steenwijk MD, Daams M, Tewarie P, Killestein J et al (2014) A dam for retrograde axonal degeneration in multiple sclerosis? J Neurol Neurosurg Psychiatry 85(7):782–789CrossRefPubMed Balk LJ, Twisk JW, Steenwijk MD, Daams M, Tewarie P, Killestein J et al (2014) A dam for retrograde axonal degeneration in multiple sclerosis? J Neurol Neurosurg Psychiatry 85(7):782–789CrossRefPubMed
11.
go back to reference Albrecht P, Ringelstein M, Muller AK, Keser N, Dietlein T, Lappas A et al (2012) Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler 18(10):1422–1429CrossRefPubMed Albrecht P, Ringelstein M, Muller AK, Keser N, Dietlein T, Lappas A et al (2012) Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler 18(10):1422–1429CrossRefPubMed
12.
go back to reference Gabilondo I, Martinez-Lapiscina EH, Martinez-Heras E, Fraga-Pumar E, Llufriu S, Ortiz S et al (2014) Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol 75(1):98–107CrossRefPubMed Gabilondo I, Martinez-Lapiscina EH, Martinez-Heras E, Fraga-Pumar E, Llufriu S, Ortiz S et al (2014) Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol 75(1):98–107CrossRefPubMed
13.
go back to reference Saidha S, Sotirchos ES, Oh J, Syc SB, Seigo MA, Shiee N et al (2013) Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol 70(1):34–43CrossRefPubMedPubMedCentral Saidha S, Sotirchos ES, Oh J, Syc SB, Seigo MA, Shiee N et al (2013) Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol 70(1):34–43CrossRefPubMedPubMedCentral
14.
go back to reference Tatrai E, Simo M, Iljicsov A, Nemeth J, Debuc DC, Somfai GM (2012) In vivo evaluation of retinal neurodegeneration in patients with multiple sclerosis. PLoS One 7(1):e30922CrossRefPubMedPubMedCentral Tatrai E, Simo M, Iljicsov A, Nemeth J, Debuc DC, Somfai GM (2012) In vivo evaluation of retinal neurodegeneration in patients with multiple sclerosis. PLoS One 7(1):e30922CrossRefPubMedPubMedCentral
15.
go back to reference Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ (2011) Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol 31(4):362–373CrossRefPubMedPubMedCentral Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ (2011) Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol 31(4):362–373CrossRefPubMedPubMedCentral
16.
go back to reference Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garcia-Layana A, Bejarano B, Villoslada P (2007) Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 68(18):1488–1494CrossRefPubMed Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garcia-Layana A, Bejarano B, Villoslada P (2007) Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 68(18):1488–1494CrossRefPubMed
17.
go back to reference Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, Thompson AJ et al (2005) Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 58(3):383–391CrossRefPubMed Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, Thompson AJ et al (2005) Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 58(3):383–391CrossRefPubMed
18.
go back to reference Talman LS, Bisker ER, Sackel DJ, Long DAJ, Galetta KM, Ratchford JN et al (2010) Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 67(6):749–760PubMedPubMedCentral Talman LS, Bisker ER, Sackel DJ, Long DAJ, Galetta KM, Ratchford JN et al (2010) Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 67(6):749–760PubMedPubMedCentral
19.
go back to reference Henderson APD, Trip SA, Schlottmann PG, Altmann DR, Garway-Heath DF, Plant GT et al (2010) A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. J Neurol 257(7):1083–1091CrossRefPubMed Henderson APD, Trip SA, Schlottmann PG, Altmann DR, Garway-Heath DF, Plant GT et al (2010) A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. J Neurol 257(7):1083–1091CrossRefPubMed
20.
go back to reference Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133(Pt 6):1591–1601CrossRefPubMedPubMedCentral Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133(Pt 6):1591–1601CrossRefPubMedPubMedCentral
21.
go back to reference Gelfand JM, Goodin DS, Boscardin WJ, Nolan R, Cuneo A, Green AJ (2012) Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One 7(5):e36847CrossRefPubMedPubMedCentral Gelfand JM, Goodin DS, Boscardin WJ, Nolan R, Cuneo A, Green AJ (2012) Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One 7(5):e36847CrossRefPubMedPubMedCentral
22.
go back to reference Young KL, Brandt AU, Petzold A, Reitz LY, Lintze F, Paul F et al (2013) Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. Eur J Neurol 20(5):803–811CrossRefPubMed Young KL, Brandt AU, Petzold A, Reitz LY, Lintze F, Paul F et al (2013) Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. Eur J Neurol 20(5):803–811CrossRefPubMed
23.
go back to reference Oberwahrenbrock T, Ringelstein M, Jentschke S, Deuschle K, Klumbies K, Bellmann-Strobl J et al (2013) Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler 19(14):1887–1895CrossRefPubMed Oberwahrenbrock T, Ringelstein M, Jentschke S, Deuschle K, Klumbies K, Bellmann-Strobl J et al (2013) Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler 19(14):1887–1895CrossRefPubMed
24.
go back to reference Huhn K, Lammer R, Oberwahrenbrock T, Lammer A, Waschbisch A, Gosar D et al (2014) Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage. Eur J Neurol 22(1):86–92CrossRefPubMed Huhn K, Lammer R, Oberwahrenbrock T, Lammer A, Waschbisch A, Gosar D et al (2014) Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage. Eur J Neurol 22(1):86–92CrossRefPubMed
25.
go back to reference Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46(4):907–911CrossRefPubMed Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46(4):907–911CrossRefPubMed
26.
go back to reference Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452CrossRefPubMed Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452CrossRefPubMed
27.
go back to reference Petzold A, Wattjes MP, Costello F, Flores-Rivera J, Fraser CL, Fujihara K et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10(8):447–458CrossRefPubMed Petzold A, Wattjes MP, Costello F, Flores-Rivera J, Fraser CL, Fujihara K et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10(8):447–458CrossRefPubMed
28.
go back to reference Balk LJ, Petzold A (2013) Influence of the eye-tracking-based follow-up function in retinal nerve fiber layer thickness using fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci 54(4):3045CrossRefPubMed Balk LJ, Petzold A (2013) Influence of the eye-tracking-based follow-up function in retinal nerve fiber layer thickness using fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci 54(4):3045CrossRefPubMed
29.
go back to reference Schippling S, Balk L, Costello F, Albrecht P, Balcer L, Calabresi P et al (2014) Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler 21(2):163–170CrossRefPubMed Schippling S, Balk L, Costello F, Albrecht P, Balcer L, Calabresi P et al (2014) Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler 21(2):163–170CrossRefPubMed
30.
go back to reference Burggraaff MC, Trieu J, de Vries-Knoppert WA, Balk L, Petzold A (2014) The clinical spectrum of microcystic macular edema. Invest Ophthalmol Vis Sci 55(2):952–961CrossRefPubMed Burggraaff MC, Trieu J, de Vries-Knoppert WA, Balk L, Petzold A (2014) The clinical spectrum of microcystic macular edema. Invest Ophthalmol Vis Sci 55(2):952–961CrossRefPubMed
31.
go back to reference Costello F, Hodge W, Pan YI, Freedman M, DeMeulemeester C (2009) Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes. J Neurol Sci 281(1–2):74–79CrossRefPubMed Costello F, Hodge W, Pan YI, Freedman M, DeMeulemeester C (2009) Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes. J Neurol Sci 281(1–2):74–79CrossRefPubMed
32.
go back to reference Narayanan D, Cheng H, Bonem KN, Saenz R, Tang RA, Frishman LJ (2014) Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Mult Scler 20(10):1331–1341CrossRefPubMedPubMedCentral Narayanan D, Cheng H, Bonem KN, Saenz R, Tang RA, Frishman LJ (2014) Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Mult Scler 20(10):1331–1341CrossRefPubMedPubMedCentral
33.
go back to reference Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD et al (2015) Optical coherence tomography reflects brain atrophy in MS: a four year study. Ann Neurol. doi:10.1002/ana.24487 Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD et al (2015) Optical coherence tomography reflects brain atrophy in MS: a four year study. Ann Neurol. doi:10.​1002/​ana.​24487
34.
go back to reference Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 135(Pt 6):1786–1793CrossRefPubMedPubMedCentral Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 135(Pt 6):1786–1793CrossRefPubMedPubMedCentral
35.
go back to reference Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ et al (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 11(11):963–972CrossRefPubMedPubMedCentral Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ et al (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 11(11):963–972CrossRefPubMedPubMedCentral
36.
go back to reference Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A et al (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921–932CrossRefPubMed Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A et al (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921–932CrossRefPubMed
37.
go back to reference Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E et al (2012) Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 135(Pt 2):521–533CrossRefPubMed Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E et al (2012) Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 135(Pt 2):521–533CrossRefPubMed
38.
go back to reference Gabilondo I, Martinez-Lapiscina EH, Fraga-Pumar E, Ortiz-Perez S, Torres-Torres R, Andorra M et al (2015) Dynamics of retinal injury after acute optic neuritis. Ann Neurol 77(3):517–528CrossRefPubMed Gabilondo I, Martinez-Lapiscina EH, Fraga-Pumar E, Ortiz-Perez S, Torres-Torres R, Andorra M et al (2015) Dynamics of retinal injury after acute optic neuritis. Ann Neurol 77(3):517–528CrossRefPubMed
Metadata
Title
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study
Authors
Lisanne J. Balk
Andrés Cruz-Herranz
Philipp Albrecht
Sam Arnow
Jeffrey M. Gelfand
Prejaas Tewarie
Joep Killestein
Bernard M. J. Uitdehaag
Axel Petzold
Ari J. Green
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 7/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8127-y

Other articles of this Issue 7/2016

Journal of Neurology 7/2016 Go to the issue